GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Valbiotis SA (XPAR:ALVAL) » Definitions » Other Stockholders Equity

Valbiotis (XPAR:ALVAL) Other Stockholders Equity : €7.16 Mil (As of Dec. 2023)


View and export this data going back to 2017. Start your Free Trial

What is Valbiotis Other Stockholders Equity?

Valbiotis's Other Stockholders Equity for the quarter that ended in Dec. 2023 was €7.16 Mil.

Valbiotis's quarterly Other Stockholders Equity increased from Dec. 2022 (€-12.67 Mil) to Jun. 2023 (€6.77 Mil) and increased from Jun. 2023 (€6.77 Mil) to Dec. 2023 (€7.16 Mil).

Valbiotis's annual Other Stockholders Equity declined from Dec. 2021 (€-10.33 Mil) to Dec. 2022 (€-12.67 Mil) but then increased from Dec. 2022 (€-12.67 Mil) to Dec. 2023 (€7.16 Mil).

Valbiotis Other Stockholders Equity Historical Data

The historical data trend for Valbiotis's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Valbiotis Other Stockholders Equity Chart

Valbiotis Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Stockholders Equity
Get a 7-Day Free Trial Premium Member Only -7.19 -12.00 -10.33 -12.67 7.16

Valbiotis Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -10.33 -14.31 -12.67 6.77 7.16

Valbiotis Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

Valbiotis Other Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Valbiotis's Other Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Valbiotis (XPAR:ALVAL) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Valbiotis SA (XPAR:ALVAL) » Definitions » Other Stockholders Equity
Comparable Companies
XPAR:MAAT XPAR:ALCLS XPAR:ALACT XPAR:OSE XPAR:ADOC XPAR:ABNX XPAR:ALGEN XPAR:GNRO XPAR:ALVIO XPAR:PHXM OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
8JD:Germany
Address
12F rue Paul VATINE, Perigny, La Rochelle, FRA, 17180
Website
http://www.valbiotis.com
Valbiotis SA is a research & development company. It is engaged in scientific innovation for preventing and combating metabolic diseases. Valbiotis has adopted an approach, aiming to revolutionize healthcare by developing a new class of Nutrition Health products designed to reduce the risk of major metabolic diseases, based on a multi-target approach by the use of plant-based ingredients.

Valbiotis (XPAR:ALVAL) Headlines

No Headlines